AGA Family of Websites:

Effective strategies to help IBD patients transition to biosimilars

This new AGA program includes on-demand videos, a podcast series and more.
Biosimilars Addressing the Knowledge Gaps Asset Package_EDIGEST_LEAD_650x300
Biosimilars Addressing the Knowledge Gaps Asset Package_EDIGEST_LEAD_650x300

To help guide GI clinicians to support patients who are concerned about switching from biologics to biosimilars, AGA has launched Biosimilars: Addressing the Knowledge Gaps, which includes on-demand videos, an infographic in English and Spanish and a four-part podcast series hosted by Christina Ha, MD, FACG, AGAF.

During the series you will learn how to introduce a patient to the idea of using biosimilars for their IBD treatment, ways to reassure them about switching during their therapy, and how to ensure messaging from all providers who part of the care team is consistent.

Dr. Ha's podcast discussion topics

  • Starting a patient on biologic therapy with Frank Scott, MD.
  • Managing switch scenarios with biologics and biosimilars with Frank Scott, MD.
  • The logistics of switching between biosimilars or between biosimilars and reference product with Jennifer Seminerio-Diehl, MD, and Shuba Bhat, PharmD, MS, BCACP.
  • Communicating with a patient who does not want to switch with Miguel Regueiro, MD, and Shuba Bhat, PharmD, MS, BCACP.

The podcasts are hosted on AGA’s Inside Scope. Subscribe on Apple or Google, or wherever you listen podcasts. To collect CME for listening, visit AGA University.

Downloadable infographic

The infographic Biologic or Biosimilar? It doesn’t matter which can be downloaded or printed and used in shared decision making with your patients.

This series is supported by independent medical education grants from Amgen and Pfizer.

Your hub for GI education is
AGA University

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.